1 not yet recruiting, 1 recruiting. 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Not yet recruiting 1, Recruiting 1 |
Follow Tacrolimus 0.1%: new trials by email Literature Review of Tacrolimus 0.1% trials Research Report on Tacrolimus 0.1%
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Crisaborole 2% Versus Tacrolimus 0.1% in Children With Mild to Moderate Atopic Dermatitis Crisaborole 2%, Tacrolimus 0.1% - Atopic Dermatitis, Atopic Dermatitis (AD) | Phase 3 | Not yet recruiting | Shalamar Institute of Health Sciences | 66 | 2026-06-01 | 2025-09-09 |
| Evaluation of Crisaborole 2% Versus Tacrolimus 0.1% Each Combined With Excimer Light in the Treatment of Stable Non-segmental Facial Vitiligo: a Prospective Randomized Controlled Study. Crisaborole 2% topical ointment, tacrolimus 0.1%, Excimer Light therapy - Vitiligo, Non-Segmental Vitiligo (NSV) | Phase 3 | Recruiting | Cairo University | 35 | 2026-05-15 | 2026-10-29 |
Dermatitis, Atopic (1) · Vitiligo (1)
Cairo University (1) · Shalamar Institute of Health Sciences (1)
Egypt (1) · Pakistan (1)